Meningitis Vaccines Market, by Vaccine (Pneumococcal Conjugate Vaccine, Pneumococcal Polysaccharide Vaccine, Meningococcal Vaccine, and Others), by Age Group (Infants and Adults), by Distribution Channel (Government and Private), and by Country (Egypt, Nigeria, Morocco, Indonesia, Bangladesh, Malaysia, United Arab Emirates, Saudi Arabia, Pakistan, Turkey, Kazakhstan, Jordan, Qatar, Sudan, Lebanon, Uganda, Benin, Cameroon, Gabon, Cote d’Ivoire, Vietnam, Singapore, Mexico, Argentina, Thailand, Philippines, Nepal, Myanmar, and Rest of the World) - Size, Share, Outlook, and Opportunity Analysis, 2022 - 2030
Meningitis is an inflammation of the tissue layers that surround the brain and spinal cord (meninges) as well as the fluid-filled area between the meninges (subarachnoid space). Meningitis can be caused by bacteria, viruses, fungus, or non-infectious illnesses. Meningitis symptoms include headache, fever, and a stiff neck that makes lowering the chin to the chest difficult or impossible, though infants may not have a stiff neck and symptoms may differ in the elderly and individuals who use immune-suppressing medicines. Vaccination is a safe option to develop immunity against meningitis. Immunization of individuals most at risk of being infected helps to protect the individuals from meningitis, prevents its spread within communities, and eventually benefits the entire population. However, not all causes of meningitis and septicemia are vaccine preventable so being able to recognize the symptoms is important.
Market Dynamics
Key companies in the market are focusing on product launches and approvals for meningitis vaccines which is expected to boost the global meningitis vaccines market growth over the forecast period. For instance, in June 2021, CanSinoBIO, an innovative biopharmaceutical company, announced that the National Medical Products Administration (NMPA) of China granted approval for its Group C and Group A Meningococcal Conjugate Vaccine which has a trade name: Menphecia. Menphecia delivers protection against infection of Group A and C Neisseria meningitides.
Moreover, in May 2019, the Ministry of Health of Ireland had approved the menACWY vaccine to be administered to thousands of children & adults in Ireland due to rising cases of meningitis that were reported in 2018.
Key features of the study:
- This report provides in-depth analysis of the global meningitis vaccines market , and provides market size (US$ Million) and compound annual growth rate (CAGR%) for the forecast period (2022–2030), considering 2021 as the base year
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global meningitis vaccines market based on the following parameters – company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include GlaxoSmithKline plc., Sanofi S.A., Merck & Co., Inc., Pfizer Inc., Novartis AG, Walvax Biotechnology Co., Ltd., Incepta Pharmaceuticals Ltd., Serum Institute of India Pvt. Ltd., Vacsera, Zhi Fei Biological, BIO MED, Chengdu Kanghua Biological Products, Bharat Biotech., LG Chem, Espromed Bio, Panacea Biotec Limited, Sinovac Biotech Co., Ltd., CanSinoBIO, and Eubiologics Co., Ltd.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global meningitis vaccines market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global meningitis vaccines market
- Global Meningitis Vaccines Market, By Vaccine:
- Pneumococcal Conjugate Vaccine
- Pneumococcal Polysaccharide Vaccine
- Meningococcal Vaccine
- Others
- Global Meningitis Vaccines Market, By Age Group:
- Infants
- Adults
- Global Meningitis Vaccines Market, By Distribution Channel:
- Government
- Private
- Global Meningitis Vaccines Market, By Country:
- Egypt
- Nigeria
- Morocco
- Indonesia
- Bangladesh
- Malaysia
- United Arab Emirates
- Saudi Arabia
- Pakistan
- Turkey
- Kazakhstan
- Jordan
- Qatar
- Sudan
- Lebanon
- Uganda
- Benin
- Cameroon
- Gabon
- Cote d’Ivoire
- Vietnam
- Singapore
- Mexico
- Argentina
- Thailand
- Philippines
- Nepal
- Myanmar
- Rest of the World
- Company Profiles
- GlaxoSmithKline plc.
- Company Highlights
- Products Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Sanofi S.A.
- Merck & Co., Inc.
- Pfizer Inc.
- Novartis AG
- Walvax Biotechnology Co., Ltd.
- Incepta Pharmaceuticals Ltd.
- Serum Institute of India Pvt. Ltd.
- Vacsera
- Zhi Fei Biological
- BIO MED
- Chengdu Kanghua Biological Products
- Bharat Biotech.
- LG Chem
- Espromed Bio
- Panacea Biotec Limited
- Sinovac Biotech Co., Ltd.
- CanSinoBIO
- Eubiologics Co., Ltd.
- 1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
- 2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Snapshot, By Vaccine
- Market Snapshot, By Age Group
- Market Snapshots, By Distribution Channel
- Market Snapshot, By Country
- Coherent Opportunity Map (COM)
- 3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Restraints
- Market Opportunities
- Impact Analysis
- Market Trends
- Key Developments
- Regulatory Scenario
- PEST Analysis
- Epidemiology
- Vaccine Development Cycle
- Vaccine Types/Technology and Route of Administration
- Pricing Analysis
- Pipeline Analysis
- Brand Comparison Mapping
- 4. Global Meningitis Vaccines Market - Impact of Coronavirus (Covid-19) Pandemic
- Economic Impact
- COVID-19 Epidemiology
- Demand and Supply Analysis
- 5. Global Meningitis Vaccines Market, By Vaccine, 2017 – 2030, (US$ Million)
- Overview
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 – 2030
- Segment Trends
- Pneumococcal Conjugate Vaccine
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
- Pneumococcal Polysaccharide Vaccine
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
- Meningococcal Vaccine
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
- Others
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
- 6. Global Meningitis Vaccines Market, By Age Group, 2017 – 2030, (US$ Million)
- Overview
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 – 2030
- Segment Trends
- Infants
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
- Adults
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
- 7. Global Meningitis Vaccines Market, By Distribution Channel, 2017 – 2030, (US$ Million)
- Overview
- Market Share Analysis, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, 2018 – 2030
- Segment Trends
- Government
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
- Private
- Overview
- Market Size and Forecast, and Y-o-Y Growth, 2017–2030, (US$ Million)
- 8. Global Meningitis Vaccines Market, By Country, 2017 – 2030, (US$ Million)
- Introduction
- Market Share Analysis, By Country, 2022 and 2030 (%)
- Y-o-Y Growth Analysis, For Countries, 2018–2030
- Country Trends
- Egypt
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
- Nigeria
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
- Morocco
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
- Indonesia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
- Bangladesh
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
- Malaysia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
- United Arab Emirates
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
- Saudi Arabia
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
- Pakistan
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
- Turkey
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
- Kazakhstan
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
- Jordan
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
- Qatar
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
- Sudan
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
- Lebanon
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
- Uganda
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
- Benin
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
- Cameroon
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
- Gabon
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
- Cote d’Ivoire
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
- Vietnam
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
- Singapore
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
- Mexico
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
- Argentina
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
- Thailand
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
- Philippines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
- Nepal
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
- Myanmar
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
- Rest of the World
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Vaccine, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2017 - 2030, (US$ Million)
- Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2017 - 2030, (US$ Million)
- 9. Competitive Landscape
- GlaxoSmithKline plc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Sanofi S.A.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Merck & Co., Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Novartis AG
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Walvax Biotechnology Co., Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Incepta Pharmaceuticals Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Serum Institute of India Pvt. Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Vacsera
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Zhi Fei Biological
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- BIO MED
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Chengdu Kanghua Biological Products
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Bharat Biotech.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- LG Chem
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Espromed Bio
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Panacea Biotec Limited
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Sinovac Biotech Co., Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- CanSinoBIO
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- Eubiologics Co., Ltd.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Market Strategies
- 10. Section
- Research Methodology
- About Us
- *Browse 98 market data tables and 45 figures on "Meningitis Vaccines Market” - Global forecast to 2030
Research Assistance
Download our eBook: How to Succeed Using Market Research
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook